Feldman S, Zhang J, Martinez D, et al. Real-world treatment patterns of biologics, apremilast among patients with moderate to severe plaque psoriasis by metabolic syndrome status [abstract L11]. J Manag Care Spec Pharm. 2019, 25(suppl 10-a):S78. doi: 10.18553/jmcp.2019.25.10-a.s1.
Advertisement
Articles by Feldman S, Zhang J, Martinez D, et al. Real-world treatment patterns of biologics, apremilast among patients with moderate to severe plaque psoriasis by metabolic syndrome status [abstract L11]. J Manag Care Spec Pharm. 2019, 25(suppl 10-a):S78. doi: 10.18553/jmcp.2019.25.10-a.s1.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Medicaid MFN Pricing Could Save $8.6 Billion
2
Active US Drug Shortages Rise for Third Straight Quarter
3
FAQs: FDA Lawsuit Challenges E-Cigarette Enforcement Policy, PMTA Guidance
4
CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks
5